Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “angiotensin ii”

8 pharma patents match "angiotensin ii" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 8
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 8 pharmaceutical patents matching "angiotensin ii" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

8 results for “angiotensin ii” · 30,257 patents in full index Clear search

  1. US 2025195525

    ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OF SYSTEMIC DISEASES IN CATS

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Jun 19, 2025 · Expires Jun 14, 2045

    granted
  2. US 9387249

    Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone

    Takeda Pharmaceutical Company Limited · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted
  3. US 8895755

    Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity

    Theravance Biopharma R&D IP, LLC · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  4. US 8569351

    Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity

    Theravance, Inc. · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted
  5. US 7378108

    Percutaneous absorption preparation of compound having angiotensin II antagonistic activity

    Takeda Pharmaceutical Company Limited · Granted May 27, 2008 · Expires May 22, 2028

    granted
  6. US 6420405

    Pharmaceutical composition for angiotensin II-mediated diseases

    Takeda Chemical Industries Ltd. · Granted Jul 16, 2002 · Expires Jul 11, 2022

    expired
  7. US 6348481

    Pharmaceutical composition for angiotensin II-mediated diseases

    Takeda Chemical Industries Ltd. · Granted Feb 19, 2002 · Expires Feb 14, 2022

    expired
  8. US 6228874

    Pharmaceutical composition for angiotensin II-mediated diseases

    Takeda Chemical Industries Ltd. · Granted May 8, 2001 · Expires May 3, 2021

    expired